ArticleAmerican journal of cancer research2024

Evolution and prognostic significance of HER-2 conversion from primary to residual disease in HER-2 negative patients with breast cancer after neoadjuvant chemotherapy.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.